Note: Ingredients listed on restricted chemical lists
EC/CAS
9005-25-8
Name of the chemical
Starch
Concentration
N/A
EC/CAS
9004-65-3
Name of the chemical
methylhydroxypropylcellulose
Concentration
N/A
EC/CAS
9003-39-8
Name of the chemical
polyvinylpyrrolidone
Concentration
N/A
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
N/A
General Information
Revision date
2019-11-06
Product name
VOLTAREN RAPID 12.5MG TABLETS
Product Synonyms
VOLTAREN RAPID TABLETS 12.5MG (ANZ) * MFCF.104 * DICLOFENAC POTASSIUM, FORMULATED PRODUCT
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline Australia Phamaceuticals and Vaccines
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Section 2
Physical hazards
Not classified.
Health hazards
Acute toxicity, oral Category 4 Reproductive toxicity Category 2 Specific target organ toxicity following Category 2 repeated exposure Exclamation mark
Environmental hazards
Hazardous to the aquatic environment, Category 3
Long term hazards
Label elements, including precautionary statements Hazard symbol(s)
Signal word
Warning
Hazard statements
Harmful if swallowed. Suspected of damaging fertility or the unborn child. May cause damage to organs through prolonged or repeated exposure. Harmful to aquatic life with long lasting effects.
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Do not breathe dust/fume/gas/mist/vapours/spray. Wash thoroughly after handling. Do not eat, drink or smoke when using this product. Avoid release to the environment. Use personal protective equipment as required.
Response
IF SWALLOWED: Call a POISON CENTRE or doctor/physician if you feel unwell. Rinse mouth. IF exposed or concerned: Get medical advice/attention.
Storage
Store locked up.
Disposal
Dispose of contents/container (in accordance with related regulations).
Other hazards which do not result in classification
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
Additional information
92.22 % of the mixture consists of component(s) of unknown acute dermal toxicity. 90.25 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 90.25 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
